From previous studies, lymphocyte DNA from human leukemias and DNA from involved tissues of patients with Hodgkin's disease or Burkitt's lymphoma contain sequences that are absent from their normal counterparts. These sequences are related to those found in particulate elements associated with these neoplasias and possessing biochemical properties characteristic of RNA tumor viruses. Similar observations have been made of unique sequences related to those of the feline virus RD-114 and found in spontaneous mastocytomas in cats. Here we extend these results to the classical murine model of virus-induced leukemias.
One of the key questions of viral oncology may be usefully put in the following terms: "Does the DNA of a malignant cell contain viral-related sequences that are not found in the DNA of its normal counterpart?" Phrasing the issue in this manner leads to the design of experiments that avoid the uncertainties generated by the demonstrated fact that many indigenous tumor viruses share some sequences with the normal DNA of their natural hosts (1-5, 19, 23) . The crucial point is of course whether all of the viral sequences are to be found in normal DNA. The strategy adopted requires removal of those viral sequences that are shared with normal DNA by exhaustive hybridization of the viral probe to normal DNA in vast excess. If any unhybridized residue is left, it can be used to determine whether malignant DNA contains viral-related sequences not detectable in normal tissue.
We first reported experiments along these lines with human leukemias (6) . Leukemic cells contain viral-related 70S RNA Abbreviations: RLV, Rauscher leukemia virus; AMV, avian myeloblastosis virus; EDTA, ethylenediaminetetraacetate; PB, sodium phosphate buffer; Cot, product of initial single-stranded nucleic acid concentration and time; Tei/,, temperature at which half of the hybrid was eluted from hydroxyapatite.
and an RNA-directed DNA polymerase encapsulated in particles possessing a density of about 1.16 g/cm3 (7, 8) . These particles were used to generate [3H]DNA probes from which normal sequences were removed by hybridization to normal leukocyte DNA in vast excess. The resulting residue of unpaired [3H]DNA was then annealed alternatively to the white blood cell DNA from leukemic patients and to normal DNA. The data obtained with 10 patients, including leukemic members of two sets of identical twins (9) , revealed in every instance that the DNA of leukemic cells contained particle-related sequences that could not be found in the leukocyte DNA of normal individuals. The sensitivity of these experiments was such that 1/50th of the hybridizable DNA observed in leukemic cells would have been readily detected. Since the leukemia-specific sequences are present at a level of about one per genome equivalent, these findings suggest that the vast majority of normal cells do not contain a single copy of the leukemia-specific sequences.
A parallel series of investigations was made in human lymphomas with [3H]DNA probes generated by the particles isolated from Burkitt's lymphomas and Hodgkin's disease spleens (10) . The nuclear DNAs of both of these human lymphomas contain particle-related sequences that could not be detected in the DNA of normal cells (11) .
One could argue that these findings are not relevant to animal systems that involve viral agents of established oncogenic ability. The present investigation seeks to provide the necessary data using DNA from BALB/c mice before and after infection with the Rauscher leukemia virus (RLV), a murine virus originally isolated from an induced leukemia in BALB/c (12) .
The results indicate that leukemic spleen DNA contains RLV-related sequences that are absent in normal BALB/c DNA. The data from the murine system and the conclusions derivable from them are therefore similar to those obtained with the human disease. Leukemic cells contain particle-related sequences not found in normal DNA.
MATERIALS AND METHODS
Virus. Rauscher leukemia virus (RLV) was purified from RLV-infected BALB/c plasma (University Laboratories, Highland Park, N.J.) by isopycnic sucrose centrifugation (15) . This virus stock was passaged only in BALB/c or Swiss Webster mice since its isolation by Rauscher (12 disrupted with a Silverson homogenizer. Centrifugation at 5000 X g for 10 min yielded a crude nuclear pellet, which was repeatedly homogenized and pelleted until the supernatant was clear. DNA was extracted from the pellet as previously described (16) .
RLV 70S RNA was extracted from purified virus according to previous procedures (15 Fig. 3 ; the results for the BALB/c-recycled [3H]DNA with normal and infected BALB/c DNAs are also shown in Fig. 3 (circles). The NIH-recycled [3H] DNA was prepared as described in Fig. 3 degree of homology with the total RLV [8H]DNA is about the same in all the strains examined including AKR, the strain having a high frequency of spontaneous leukemia. Again, as in Fig. 2 , DNA from RLV-infected BALB/c tissue hybridizes to a significantly greater extent than does any normal DNA. The data shown in Table 1 with the recycled RLV [3H]DNA emphasize once again that significant levels of the leukemia-specific sequences are found only in the DNA of leukemic tissues and not in the normal DNA of any of the strains examined, whether they be of high or low leukemic frequency.
The fact that all the normal DNAs tested showed the same level of hybridization with the total RLV [8H]DNA suggests that the RLV-related sequence found in normal DNA also occurs in the DNAs of the other strains examined. This conclusion was tested more directly by an experiment summarized in Table 1 (20, 21) that there is 7-8% mismatching of bases in the complexes formed with the normal as compared with the leukemic DNA. This adds further weight to the conclusion that the leukemia-specific sequences are different from those detected in normal DNAs. These results concur with the observed addition of viral sequences to cellular DNA in in vitro transformation of rodent (23, 24) , avian (25) , and simian (16) cells by nonindigenous RNA tumor viruses.
DISCUSSION
The present investigation reverses the usual order of biomedical research, since its principal-purpose is to extend to an animal model information gained from a study of human disease. To this end we chose to study BALB/c mice, a strain with a low incidence of leukemia and the indigenous murine virus RLV, an established leukemogenic agent. In complete parallelism to the human disease, we found RLV sequences in the DNA of leukemic spleens of infected mice that could not be detected in normal DNA. In the case of the human leukemias and lymphomas, the viral and etiologic relation of the particles detected was, and still remains, a moot point. The results described here with RLV establish with a known viral etiologic agent that the same pattern of unique leukemiaspecific sequences exists in the mouse as has been observed in man. It will be of great interest to extend such experiments to a spontaneous neoplasia in an animal model.
It has been suggested (22) that RLV exists in some latent form in the genome of BALB/c mice, the strain from which the virus was originally isolated (12) . The data reported here do not support this contention, since we have shown that some RLV sequences are missing from normal BALB/c DNA and that even those RLV-related sequences that are present in normal DNA appear not to be entirely homologous to RLV. Such sequences appear to be present only in leukemic DNA.
In summary, recycling experiments in lymphoid neoplasias of humans (6, 11) , cats (1) , and mice all lead to the conclusion that malignancy is associated with the addition of new particle-related sequences to the normal DNA complement. In a global biological sense no collection of individual experiments can disprove hypotheses (26, 27) that invoke the germ line transmission of a complete copy of some unspecified viral information required for malignancy and the production of an RNA tumor virus. The experiments described here and those previously reported make this hypothesis unlikely only for those particular neoplasias and associated particulate elements subjected to examination.
